Cyclic Depsipeptides and Linear Peptides With Cytotoxic and Antiphytopathogenic Activities From Symbiotic Bacteria of Xenorhabdus (Enterobacteriales: Morganellaceae) Genus

Abstract On the basis of biological activities of the ethyl acetate extracts of four Xenorhabdus sp., including Xenorhabdus nematophila FUM 220, Xenorhabdus nematophila FUM 221, Xenorhabdus bovienii FUM 222, and Xenorhabdus bovienii FUM 223, X. nematophila FUM 220 was preferentially selected to track the isolation of responsible compounds. Chemical study on the ethyl acetate extract of X. nematophila isolate FUM220 which is derived from the native nematode Steinernema carpocapsae (Rhabditida: Steinernematidae), was evaluated, and eleven compounds, including xenocoumacin II (1), xenortide-396 (2), xenortide A (3), xenortide-410 (4), xenortide-449 (5), xenematide A 663 (6), rhabdopeptide-574 (7), rhabdopeptide-588 (8), rhabdopeptide-687 (9), rhabdopeptide-701 (10), and nematophin-273 (11) were characterized. In this experimental study, we surveyed the antitumoral potential of bacterial extract and bacterial metabolites to treat human breast cancer (MCF-7), human lung cancer (A549), and murineTumor (B16) cell lines. We observed that all samples were cytotoxic, but bacterial extracts of X. nematophila FUM 220 and X. bovienii FUM 223 showed higher toxicity on mentioned cell lines. Potent cytotoxic activity was found for compounds 6 and 11 with IC50 of 6.2 µg/ml against human lung cancer A549 cell lines, too.These compounds showed moderated antibacterial activity against Xanthomonas oryzae pv. oryzae strain Xoo-IR42 (Xanthomonadales: Xanthomonadaceae) (MIC of 62.5 µg/ml) and Staphylococcus aureus strain 1112 (Bacillales: Staphylococcaceae) (MIC of 100 µg/ ml). The bacterial extracts from X. bovienii FUM 222 showed strong inhibition of the growth of S. aureus strain 1112, by a minimal inhibitory concentration assay (MIC of 53.5 µg/ml). Xenorhabdus genera produce metabolites with potent cytotoxic and antibacterial activity. Single compounds can be isolated, identified, and commercialized, but various species or strains may change their anticancer or antimicrobial potential. The present study brings new clues regarding the qualified of Xenorhabdus as future peptide sources for supplying natural bioactive compounds and challenge multidrug-resistant bacteria, treat cancer, and plant diseases. Graphical Abstract

[1]  M. Zeller,et al.  Type Strains of Entomopathogenic Nematode-Symbiotic Bacterium Species, Xenorhabdus szentirmaii (EMC) and X. budapestensis (EMA), Are Exceptional Sources of Non-Ribosomal Templated, Large-Target-Spectral, Thermotolerant-Antimicrobial Peptides (by Both), and Iodinin (by EMC) , 2022, Pathogens.

[2]  A. Panda,et al.  Antimicrobial Peptides: Novel Source and Biological Function With a Special Focus on Entomopathogenic Nematode/Bacterium Symbiotic Complex , 2021, Frontiers in Microbiology.

[3]  L. Dicks,et al.  Profiling the Production of Antimicrobial Secondary Metabolites by Xenorhabdus khoisanae J194 Under Different Culturing Conditions , 2021, Frontiers in Chemistry.

[4]  S. Sitthisak,et al.  Antibacterial activity of Xenorhabdus and Photorhabdus isolated from entomopathogenic nematodes against antibiotic-resistant bacteria , 2020, PloS one.

[5]  Emilie Racine,et al.  From Worms to Drug Candidate: The Story of Odilorhabdins, a New Class of Antimicrobial Agents , 2019, Front. Microbiol..

[6]  Zhiguo Yu,et al.  Two novel cyclic depsipeptides Xenematides F and G from the entomopathogenic bacterium Xenorhabdus budapestensis , 2019, The Journal of Antibiotics.

[7]  A. D. V. van Staden,et al.  Xenorhabdus khoisanae SB10 produces Lys-rich PAX lipopeptides and a Xenocoumacin in its antimicrobial complex , 2019, BMC Microbiology.

[8]  Sudhir Kumar,et al.  MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. , 2018, Molecular biology and evolution.

[9]  M. Karimi,et al.  Biological activities of three natural plant pigments and their health benefits , 2018, Journal of Food Measurement and Characterization.

[10]  I. Ebersberger,et al.  Natural product diversity associated with the nematode symbionts Photorhabdus and Xenorhabdus , 2017, Nature Microbiology.

[11]  Nitya V. Sharma,et al.  Effects of genistein supplementation on genome-wide DNA methylation and gene expression in patients with localized prostate cancer , 2017, International journal of oncology.

[12]  G. Chandrakasan,et al.  Xenorhabdus stockiae KT835471-mediated feasible biosynthesis of metal nanoparticles for their antibacterial and cytotoxic activities , 2017, Artificial cells, nanomedicine, and biotechnology.

[13]  Tsung-Ying Yang,et al.  Mechanisms underlying lung resistance-related protein (LRP)-mediated doxorubicin resistance of non-small cell lung cancer cells. , 2016, The Chinese journal of physiology.

[14]  K. Kazmierczak,et al.  Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam , 2016, Antimicrobial Agents and Chemotherapy.

[15]  K. Bélafi-Bakó,et al.  Effectiveness of a Peptide-rich Fraction from Xenorhabdus budapestensis Culture against Fire Blight Disease on Apple Blossoms , 2015 .

[16]  In-Jung Lee,et al.  An Insecticidal Compound Produced by an Insect-Pathogenic Bacterium Suppresses Host Defenses through Phenoloxidase Inhibition , 2014, Molecules.

[17]  S. Forst,et al.  Role of Secondary Metabolites in Establishment of the Mutualistic Partnership between Xenorhabdus nematophila and the Entomopathogenic Nematode Steinernema carpocapsae , 2014, Applied and Environmental Microbiology.

[18]  Y. Liu,et al.  Oral JS-38, a metabolite from Xenorhabdus sp., has both anti-tumor activity and the ability to elevate peripheral neutrophils. , 2014, Chinese journal of natural medicines.

[19]  A. Givaudan,et al.  Cabanillasin, a new antifungal metabolite, produced by entomopathogenic Xenorhabdus cabanillasii JM26 , 2013, The Journal of Antibiotics.

[20]  A. Fodor,et al.  Novel Anti-Microbial Peptides of Xenorhabdus Origin Against Multidrug Resistant Plant Pathogens , 2012 .

[21]  J. Solecka,et al.  Biologically active secondary metabolites from Actinomycetes , 2012, Central European Journal of Biology.

[22]  Jun Yang,et al.  An insecticidal protein from Xenorhabdus budapestensis that results in prophenoloxidase activation in the wax moth, Galleria mellonella. , 2012, Journal of invertebrate pathology.

[23]  A. Weerheim,et al.  Potent cytotoxic effects of Calomeria amaranthoides on ovarian cancers , 2011, Journal of experimental & clinical cancer research : CR.

[24]  M. Klein,et al.  Isolation and activity of Xenorhabdus antimicrobial compounds against the plant pathogens Erwinia amylovora and Phytophthora nicotianae , 2009, Journal of applied microbiology.

[25]  J. Kasapović,et al.  Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages , 2008, Cell biochemistry and function.

[26]  J. Imhoff,et al.  Linear and cyclic peptides from the entomopathogenic bacterium Xenorhabdus nematophilus. , 2008, Journal of natural products.

[27]  E. Stackebrandt,et al.  Description of four novel species of Xenorhabdus, family Enterobacteriaceae: Xenorhabdus budapestensis sp. nov., Xenorhabdus ehlersii sp. nov., Xenorhabdus innexi sp. nov., and Xenorhabdus szentirmaii sp. nov. , 2005, Systematic and applied microbiology.

[28]  M. Kimura.  A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences , 1980, Journal of Molecular Evolution.

[29]  E. Monti,et al.  Role of the lung resistance-related protein (LRP) in the drug sensitivity of cultured tumor cells. , 2002, Toxicology in vitro : an international journal published in association with BIBRA.

[30]  S. Meschinia,et al.  Role of the lung resistance-related protein ( LRP ) in the drug sensitivity of cultured tumor cells , 2002 .

[31]  M. Peel,et al.  Isolation, Identification, and Molecular Characterization of Strains of Photorhabdus luminescens from Infected Humans in Australia , 1999, Journal of Clinical Microbiology.

[32]  V. Kickhoefer,et al.  Vaults Are Up-regulated in Multidrug-resistant Cancer Cell Lines* , 1998, The Journal of Biological Chemistry.

[33]  H. Heuer,et al.  Analysis of actinomycete communities by specific amplification of genes encoding 16S rRNA and gel-electrophoretic separation in denaturing gradients , 1997, Applied and environmental microbiology.

[34]  N. Saitou,et al.  The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.

[35]  W. S. Abbott,et al.  A method of computing the effectiveness of an insecticide. 1925. , 1925, Journal of the American Mosquito Control Association.

[36]  R. Akhurst.  Xenorhabdus nematophilus subsp. poinarii: Its Interaction with Insect Pathogenic Nematodes , 1986 .

[37]  J. Felsenstein.  CONFIDENCE LIMITS ON PHYLOGENIES: AN APPROACH USING THE BOOTSTRAP , 1985, Evolution; international journal of organic evolution.

[38]  R. Akhurst.  Antibiotic activity of Xenorhabdus spp., bacteria symbiotically associated with insect pathogenic nematodes of the families Heterorhabditidae and Steinernematidae. , 1982, Journal of general microbiology.